Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
grade C 1.79 -5.79% -0.11
AYTU closed down 5.79 percent on Friday, March 22, 2019, on 66 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical AYTU trend table...

Date Alert Name Type % Chg
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Calm After Storm Range Contraction 0.00%
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 21 Calm After Storm Range Contraction -5.79%
Mar 21 Upper Bollinger Band Walk Strength -5.79%
Mar 21 Inside Day Range Contraction -5.79%
Mar 21 Wide Bands Range Expansion -5.79%

Older signals for AYTU ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Healthcare Organ Systems Prostate Cancer Alcohols Hormones Ketones Company's Pipeline Urinary Tract Infections Androstanes Estrogens Male Infertility Testosterone
Is AYTU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.2
52 Week Low 0.68
Average Volume 1,119,894
200-Day Moving Average 2.7245
50-Day Moving Average 1.2481
20-Day Moving Average 1.4805
10-Day Moving Average 1.726
Average True Range 0.2302
ADX 42.78
+DI 40.6591
-DI 13.9213
Chandelier Exit (Long, 3 ATRs ) 1.8394
Chandelier Exit (Short, 3 ATRs ) 1.6906
Upper Bollinger Band 2.0724
Lower Bollinger Band 0.8886
Percent B (%b) 0.76
BandWidth 79.959473
MACD Line 0.2003
MACD Signal Line 0.157
MACD Histogram 0.0433
Fundamentals Value
Market Cap 7.2 Million
Num Shares 4.02 Million
EPS -48.30
Price-to-Earnings (P/E) Ratio -0.04
Price-to-Sales 4.58
Price-to-Book 0.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.12
Resistance 3 (R3) 2.14 2.04 2.07
Resistance 2 (R2) 2.04 1.96 2.04 2.05
Resistance 1 (R1) 1.92 1.91 1.87 1.90 2.03
Pivot Point 1.82 1.82 1.80 1.82 1.82
Support 1 (S1) 1.70 1.74 1.65 1.68 1.55
Support 2 (S2) 1.60 1.69 1.60 1.53
Support 3 (S3) 1.48 1.60 1.52
Support 4 (S4) 1.46